All news

CVS faces $720 million Star ratings headwind

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

CVS Health faces headwinds after a drop in its Medicare Advantage Star ratings for 2027, with the share of enrollees in 4-star rated plans falling significantly. TD Cowen estimates an approximate $720 million impact in 2028, equal to a $0.41 hit to adjusted EPS and a 5% headwind to 2028 adjusted EPS growth. CVS is expected to detail the impact and mitigation strategies at its third-quarter earnings report.

Read original source

CVS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.